(As of 12/31/2025)

NBI Innovators Fund Investor Series

(Global Equity)
FundGrade A+® Rating recipient
For more information about FundGrade click here
2023





Inception Return
(8/31/1995) 		10.30 %
YTD Return 8.29 %
NAVPS
(2/3/2026) 		$86.55
Change ($1.55) / -1.76 %
Growth of $10,000 (As of December 31, 2025)
MER 2.24 %
Assets ($mil) $281.59
Rank (1Yr) 1580/2074
Std Dev (3Yr) 15.01 %
Volatility Ranking (3Yr) 9/10
RRSP Eligibility Yes
Load No Load
Max Front End -
Max Back End -
Sales Status Open
 
Objective
The NBI Innovators Fund (formerly NBI Science and Technology Fund) aims to aggressively seek capital appreciation for investors over the long term (greater than five years) primarily by investing in global companies whose activities are partially focused on scientific and technological research.
Fund Manager

National Bank Investments Inc.

Portfolio Manager

National Bank Trust Inc.

Sub-Advisor

Iain Stealey, J.P. Morgan Investment Management Inc.

Robert C. Michele, J.P. Morgan Investment Management Inc.

Lisa Coleman, J.P. Morgan Investment Management Inc.

Andrew Headley, J.P. Morgan Investment Management Inc.

Jeffrey Hutz, J.P. Morgan Investment Management Inc.

Robert Cook , J.P. Morgan Investment Management Inc.

Thomas Hauser, J.P. Morgan Investment Management Inc.

Jeffrey Lovell, J.P. Morgan Investment Management Inc.

Manish Goyal, J.P. Morgan Investment Management Inc.

 
Asset Allocation
(As of December 31, 2025)
Sector Allocation
(As of December 31, 2025)
Geographic Allocation
(As of December 31, 2025)
Top 10 Holdings
NameAssetSectorGeographicPercent
NVIDIA CorpUS EquityTechnologyUnited States7.46%
Microsoft CorpUS EquityTechnologyUnited States7.13%
Amazon.com IncUS EquityConsumer ServicesUnited States6.35%
Apple IncUS EquityTechnologyUnited States4.41%
Meta Platforms Inc Cl AUS EquityTechnologyUnited States3.40%
Walmart IncUS EquityConsumer ServicesUnited States3.24%
Alphabet Inc Cl AUS EquityTechnologyUnited States2.97%
Broadcom IncUS EquityTechnologyUnited States2.61%
Corpay IncUS EquityFinancial ServicesUnited States2.04%
Boston Scientific CorpUS EquityHealthcareUnited States2.00%

Performance Data (As of December 31, 2025)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund -2.53 -0.70 8.27 8.29 8.29 22.27 12.71 17.08
Benchmark -0.91 1.63 11.64 16.60 16.60 20.86 12.65 11.59
Quartile Ranking 4 4 3 4 4 1 1 1

Calendar Return (%) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Fund 8.29 30.59 29.26 -12.89 14.22 37.42 35.74 4.61 26.55 7.74
Benchmark 16.60 26.84 19.37 -12.64 17.62 13.15 21.41 -1.79 16.29 5.18
Quartile Ranking 4 1 1 2 3 1 1 1 1 1

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2026 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.